RESEARCH TRIANGLE PARK, NC – The Hamner Institutes for Health Sciences and the University of North Carolina at Chapel Hill announced they are establishing a joint Center for Drug Safety Sciences that will be led by Dr. Paul Watkins, one of the world’s leading experts in drug-induced liver injury.
The Center for Drug Safety Sciences is a unique collaboration between The Hamner Institutes, a private nonprofit translational-research organization in Research Triangle Park, and the School of Medicine and the UNC Eshelman School of Pharmacy at UNC-Chapel Hill.
The Hamner Institutes and the University have committed to spend at least $10 million over the next three years to launch the center and its research and training programs.
A new 14,000 square-foot, state-of-the-art research laboratory that will open in early 2009 at the Hamner Institutes is included in the funding commitments, along with several new joint faculty appointments from the schools of medicine and pharmacy at UNC-Chapel Hill.
On the Web: www.thehamner.org; www.unc.med.edu; www.unc.pharmacy.edu
- NC’s Hamner Institutes and UNC collaborate on commercializing research
- Dow Chemical commits $5M to Hamner Institutes for chemical safety
- NC-based Hamner Institutes may add 400 jobs on heels of China deal
- Hamner Institute research lands $25K grant
- Hamner Institutes, SynecorLabs launching Biomedical Innovation Network
© 2008, TechJournal. All rights reserved.